Results 41 to 50 of about 71,352 (148)

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration

International Journal of Retina and Vitreous, 2023
Background Significant diurnal fluctuation of optical coherence tomography (OCT)-based macular fluid occurs in patients with several macular conditions including diabetic macular edema (DME) and cystoid macular edema due to retinal venous occlusion (RVO).
Blake H. Fortes, Aaron M. Fairbanks, Aravindh A. Nirmalan, David O. Hodge, Kevin Ferenchak, Andrew J. Barkmeier   +5 more
doaj   +1 more source

The prevalence of age-related macular degeneration and osteoporosis in the older Polish population: Is there a link?

PLoS ONE, 2023
BackgroundAge-related macular degeneration is the primary cause of irreversible blindness in developed countries, whereas the global prevalence of osteoporosis-a major public health problem-is 19.7%.
Agnieszka Budnik, Marcin Palewski, Magdalena Michnowska-Kobylińska, Łukasz Lisowski, Magda Łapińska, Zofia Stachurska, Anna Szpakowicz, Jerzy Konstantynowicz, Karol Kamiński, Joanna Konopińska   +9 more
doaj   +1 more source

Uncomplicated Cataract Surgery and Neovascular Conversion of Age-Related Macular Degeneration: Fifteen-Year Follow-Up Study

Journal of Current Ophthalmology
Purpose: To evaluate the impact of cataract surgery on neovascular age-related macular degeneration (nAMD) conversion over a 15-year follow-up period. Methods: This 15-year retrospective study on dry AMD patients compared Group A (cataract surgery) and ...
Komal Agarwal, Elham Sadeghi, Kunaal Mehrotra, Sandeep Chandra Bollepalli, Kiran Kumar Vupparaboina, Jay Chhablani   +5 more
doaj   +1 more source

Pharmacogenetics and Age-Related Macular Degeneration

Journal of Ophthalmology, 2011
Pharmacogenetics seeks to explain interpatient variability in response to medications by investigating genotype-phenotype correlations. There is a small but growing body of data regarding the pharmacogenetics of both nonexudative and exudative age ...
Stephen G. Schwartz, Milam A. Brantley
doaj   +1 more source

Metabolomics and Age-Related Macular Degeneration

Metabolites, 2018
Age-related macular degeneration (AMD) leads to irreversible visual loss, therefore, early intervention is desirable, but due to its multifactorial nature, diagnosis of early disease might be challenging.
Connor N. Brown, Brian D. Green, Richard B. Thompson, Anneke I. den Hollander, Imre Lengyel, on behalf of the EYE-RISK consortium   +5 more
doaj   +1 more source

Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. [PDF]

PLoS ONE, 2018
Late-stage age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly with a complex etiology. The most important non-modifiable risk factors for onset and progression of late AMD are age and genetic risk factors ...
Thomas W Winkler, Caroline Brandl, Felix Grassmann, Mathias Gorski, Klaus Stark, Julika Loss, Bernhard H F Weber, Iris M Heid, International Age-related Macular Degeneration Genomics Consortium (IAMDGC)   +8 more
doaj   +1 more source

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients

Journal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi, Golnoush Mahmoudinezhad, Nicola Valsecchi, Sharat Chandra Vupparaboina, Sandeep Chandra Bollepalli, Kiran Kumar Vupparaboina, Jose-Alain Sahel, Andrew W. Eller, Jay Chhablani   +8 more
doaj   +1 more source

Age-related macular degeneration [PDF]

Postgraduate Medical Journal, 1998
Summary Macular degeneration is now responsible for approximately 95% of blindness and partial sighted registrations in the UK. This review has been written specifically to make the general medical community of the UK aware of the prevalence and clinical manifestations of aged-related macular degeneration. The review encompasses the risk
openaire   +2 more sources

Micronutrients in Age-Related Macular Degeneration [PDF]

Ophthalmologica, 2012
Several lines of evidence from in vitro and in vivo studies suggest that specific micronutrients may have beneficial effects in age-related macular degeneration (AMD). Such effects appear to be complex and may include filtering short wavelength light and attenuating oxidative and inflammatory damage as well as other structural and physiological factors.
Aslam, Tariq; id_orcid 0000-0002-9739-7280, Delcourt, Cécile, Silva, Rufino, Holz, Frank G., Leys, Anita, Garcià Layana, Alfredo, Souied, Eric   +6 more
openaire   +3 more sources

Macular pigment and age related macular degeneration [PDF]

British Journal of Ophthalmology, 1999
The yellow coloration of the macula lutea is attributable to the presence of macular pigment in the axons of its photoreceptors.1 In the 1980s several investigators demonstrated that macular pigment consists of the xanthophyll isomers, lutein and zeaxanthin.2 3 Although the role of the macular pigment remains uncertain, several functions have been ...
Beatty, S., Boulton, M., Henson, D., Koh, H. H., Murray, I. J.   +4 more
openaire   +3 more sources